166 results on '"Foulon S"'
Search Results
2. Association of cabozantinib pharmacokinetics, progression and toxicity in metastatic renal cell carcinoma patients: results from a pharmacokinetics/pharmacodynamics study
3. A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial
4. ADI finite difference schemes for option pricing in the Heston model with correlation
5. A path integral approach to closed-form option pricing formulas with applications to stochastic volatility and interest rate models
6. Density of a gas of spin polarized fermions in a magnetic field
7. Confined Harmonically Interacting Spin-Polarized Fermions in a Magnetic Field: Thermodynamics
8. Evaluating immunotherapy-related adverse events reporting in the French national hospital discharge database (PMSI): a pilot study
9. 1319P Impact of concomitant co-medications on survival with first-line pembrolizumab in 43,000 French patients with advanced NSCLC.
10. First multicentric randomized phase II trial investigating the antitumor efficacy of peptide receptor radionuclide therapy with 177Lutetium – Octreotate (OCLU) in unresectable progressive neuroendocrine pancreatic tumor: Results of the OCLURANDOM trial, on behalf of the ENDOCAN RENATEN network and GTE
11. 887O First multicentric randomized phase II trial investigating the antitumor efficacy of peptide receptor radionucleide therapy with 177Lutetium-Octreotate (OCLU) in unresectable progressive neuroendocrine pancreatic tumor: Results of the OCLURANDOM trial
12. 1361MO 8-month PSA strongly predicts outcomes of men with metastatic castration-sensitive prostate cancer in the PEACE-1 phase III trial
13. 1421P Effect of abiraterone-prednisone in metastatic castration-sensitive prostate cancer (mCSPC) with neuroendocrine and very high-risk features in the PEACE-1 trial
14. 1717TiP CARE1 pragmatic clinical trial: First line randomised study platform to optimize treatment in patients with metastatic renal cell carcinoma
15. 1627P Long survivors after androgen deprivation therapy (ADT) with or without docetaxel for metastatic castration-sensitive prostate cancer (mCSPC): Long-term follow-up of GETUG-15
16. 1595MO Phenotypic and genomic characterization of de novo metastatic prostate cancer: An ancillary study of the PEACE-1 phase III trial
17. Contribution of X-ray Spectroscopy to Mineralogy: Exploring Platinum Using High-Energy Resolution Fluorescence Detection X-ray Absorption Spectroscopy, HERFD-XAS
18. Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 x 2 factorial design
19. Severe COVID-19 in patients with hematological cancers presenting with viremia
20. 646TiP A randomized phase III, factorial design, of cabazitaxel and pelvic radiotherapy in patients with localized prostate cancer and high-risk features of relapse: The PEACE 2 trial from Unicancer
21. 603P Objective computerized cognitive assessment in men with metastatic castrate-resistant prostate cancer (mCRPC) randomly receiving darolutamide or enzalutamide in the ODENZA trial
22. LBA5 A phase III trial with a 2x2 factorial design in men with de novo metastatic castration-sensitive prostate cancer: Overall survival with abiraterone acetate plus prednisone in PEACE-1
23. 1639P Impact of COVID-19 on ongoing oncological and hematological treatment strategy
24. Qual Life Res
25. A randomized phase III, factorial design, of cabazitaxel and pelvic radiotherapy in patients with localized prostate cancer and high-risk features of relapse: The PEACE 2 trial from Unicancer
26. 736P Residual masses after salvage chemotherapy in men with metastatic seminoma: The Semi-ResMass multicenter retrospective study
27. THROMBOLYSIS RATE AND IMPACT OF A STROKE CODE: A FRENCH HOSPITAL EXPERIENCE AND SYSTEMATIC REVIEW: 3
28. 727P Cabozantinib (Cabo) concentration (Cmin) association with toxicity (tox) and treatment failure in metastatic renal cell carcinoma (mRCC) patients: The MONICA study
29. 1688P Outcome of older cancer patients infected with COVID-19 at Gustave Roussy Cancer Center
30. Abstract
31. Prévalence de la leucémie myéloïde chronique en 2014 en France à partir des données du Système national des données de santé
32. Health-related quality of life in patients with advanced soft tissue sarcoma (ASTS): Results from the TSAR randomized phase III trial of the French Sarcoma Group
33. 63Outsourcing telecardiology services: the possible decline in clinical workload could be lower than expected
34. 64Patient driven contacts: an unforseen burden for a telecardiology service
35. P1227A prospective analysis of the detailed workload of a telecardiology service
36. P423A retrospective analysis of the workload in a telecardiology service
37. Rôle de la radiothérapie ablative des métastases chez les patients atteints de cancer de la prostate oligométastatique hormonosensible : un essai du Groupe d’étude des tumeurs urogénitales et de l’Association française d’urologie
38. P1772Leadless cardiac pacing system as first choice within patients with challenging conditions for conventional pacing
39. Clozapine : les dernières recommandations de la FDA et nous…
40. How should we treat castration-resistant prostate cancer patients who have received androgen deprivation therapy (ADT) plus docetaxel upfront for hormone-sensitive diseae? Mature analysis of the GETUG-AFU 15 phase III trial
41. Results of a prospective randomized phase III T-SAR trial comparing trabectedin vs best supportive care (BSC) in patients with pretreated advanced soft tissue sarcoma (ASTS)
42. Prise en charge des patients atteints de sclérose en plaques en France en 2013–Consommations de soins et montants remboursés par l’Assurance maladie
43. 1604PD - Health-related quality of life in patients with advanced soft tissue sarcoma (ASTS): Results from the TSAR randomized phase III trial of the French Sarcoma Group
44. Système de transmission sans fil
45. Systèmes radiofréquences avancés pour communication inter-puces multi-gigabits à 60GHz
46. ADI finite difference schemes for option pricing in the Heston model with correlation
47. L’échantillon généraliste des bénéficiaires : un outil pour l’évaluation du risque vaccinal ?
48. Plans expérimentaux utilisés dans les études de pharmaco-épidémiologie menées sur bases de données de santé : une revue systématique
49. Déterminants de l’attrition dans un essai randomisé d’intervention auprès de mères présentant des facteurs de vulnérabilité psychosociale : une étude ancillaire de l’essai CAPEDP
50. Plans expérimentaux utilisés dans les études de pharmacoépidémiologie sur BDD de santé
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.